Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Healthcare | 16.97% |
| 3 | Consumer Discretionary | 12.86% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Hope Bancorp
HOPE
$1.86B
| $1.36M | ﹤0.01% |
162,000
-46,864
| -22% | -$409K |
|
2252
Perma-Fix Environmental Services
PESI
$385M
| $1.36M | ﹤0.01% |
124,196
+12,500
| +11% | +$130K |
|
2253
Perella Weinberg Partners
PWP
$1.33B
| $1.36M | ﹤0.01% |
163,800
+5,000
| +3% | +$41.3K |
|
2254
Victory Capital Holdings
VCTR
$7.21B
| $1.36M | ﹤0.01% |
43,200
+10,900
| +34% | +$337K |
|
|
HSAI
2255
Hesai Group
HSAI
$2.86B
| $1.36M | ﹤0.01% |
+129,371
| New | +$1.29M |
|
2256
Vanguard Russell 2000 ETF
VTWO
$17.5B
| $1.36M | ﹤0.01% |
+18,000
| New | +$1.3M |
|
|
SPPI
2257
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.36M | ﹤0.01% |
1,417,567
+450,167
| +47% | +$445K |
|
2258
Seer Inc
SEER
$117M
| $1.36M | ﹤0.01% |
318,300
-40,100
| -11% | -$157K |
|
2259
Senseonics Holdings Inc
SENS
$404M
| $1.36M | ﹤0.01% |
+88,972
| New | +$1.22M |
|
2260
Claros Mortgage Trust
CMTG
$268M
| $1.36M | ﹤0.01% |
119,600
-46,700
| -28% | -$525K |
|
2261
Gold Royalty Corp
GROY
$736M
| $1.36M | ﹤0.01% |
766,200
+543,686
| +244% | +$1.12M |
|
2262
Banner Corp
BANR
$2.52B
| $1.35M | ﹤0.01% |
30,999
+22,499
| +265% | +$1.06M |
|
2263
Cadre Holdings
CDRE
$1.46B
| $1.35M | ﹤0.01% |
62,100
+3,700
| +6% | +$78.7K |
|
2264
Atossa Therapeutics
ATOS
$25.3M
| $1.35M | ﹤0.01% |
71,605
+9,200
| +15% | +$112K |
|
2265
iShares MSCI Italy ETF
EWI
$1.08B
| $1.35M | ﹤0.01% |
+42,300
| New | +$1.32M |
|
2266
Hippo Holdings
HIPO
$875M
| $1.34M | ﹤0.01% |
81,304
-4,900
| -6% | -$85K |
|
2267
Hooker Furnishings Corp
HOFT
$158M
| $1.34M | ﹤0.01% |
72,000
+2,800
| +4% | +$47.5K |
|
2268
Yatra Online
YTRA
$54.7M
| $1.34M | ﹤0.01% |
678,136
-14,600
| -2% | -$30.3K |
|
2269
Ocugen
OCGN
$444M
| $1.34M | ﹤0.01% |
2,471,156
+189,608
| +8% | +$122K |
|
2270
Capital Group International Focus Equity ETF
CGXU
$6.65B
| $1.34M | ﹤0.01% |
57,000
+47,400
| +494% | +$1.1M |
|
|
TRML
2271
DELISTED
Tourmaline Bio
TRML
| $1.34M | ﹤0.01% |
44,080
+38,540
| +696% | +$984K |
|
2272
Zegna
ZGN
$3.68B
| $1.34M | ﹤0.01% |
+105,556
| New | +$1.31M |
|
|
INZY
2273
DELISTED
Inozyme Pharma
INZY
| $1.33M | ﹤0.01% |
239,200
+53,100
| +29% | +$314K |
|
|
EWCZ
2274
DELISTED
European Wax Center
EWCZ
| $1.33M | ﹤0.01% |
71,400
+11,900
| +20% | +$213K |
|
2275
LENSAR
LNSR
$102M
| $1.33M | ﹤0.01% |
312,895
-1,700
| -0.5% | -$5.18K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.